Literature DB >> 14765991

Identification and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein.

J N Boustead1, C C Martin, J K Oeser, C A Svitek, S I Hunter, J C Hutton, R M O'Brien.   

Abstract

Glucose-6-phosphatase (G6Pase) catalyzes the final step in the gluconeogenic and glycogenolytic pathways, the hydrolysis of glucose-6-phosphate (G6P) to glucose and phosphate. This paper describes the identification and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed G6Pase catalytic subunit-related protein (UGRP). The open reading frame of this UGRP cDNA encodes a protein (346 amino acids (aa); Mr 38,755) that shares 36% overall identity (56% similarity) with the mouse G6Pase catalytic subunit (357 aa; Mr 40,454). UGRP exhibits a similar predicted transmembrane topology and conservation of many of the catalytically important residues with the G6Pase catalytic subunit; however, unlike the G6Pase catalytic subunit, UGRP does not catalyze G6P hydrolysis and does not contain a carboxy-terminal di-lysine endoplasmic reticulum retention signal. UGRP mRNA was detected by RNA blot analysis in every mouse tissue examined with the highest expression in heart, brain, testis and kidney. Database analysis showed that the mouse UGRP gene is composed of six exons, spans approximately 4.2 kbp of genomic DNA and is located on chromosome 11 along with the G6Pase catalytic subunit gene. The UGRP gene transcription start sites were mapped by primer extension analysis, and the activity of the mouse UGRP gene promoter was analyzed using luciferase fusion gene constructs. In contrast to the G6Pase catalytic subunit gene promoter, the UGRP promoter was highly active in all cell lines examined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14765991     DOI: 10.1677/jme.0.0320033

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  10 in total

1.  Mutations in G6PC2 do not contribute to monogenic forms of early infancy diabetes and beta cell dysfunction.

Authors:  A Bonnefond; N Bouatia-Naji; A Simon; C Saint-Martin; A Dechaume; P de Lonlay; M Polak; C Bellanné-Chantelot; P Froguel; M Vaxillaire
Journal:  Diabetologia       Date:  2009-02-24       Impact factor: 10.122

Review 2.  Glucose-6-phosphatase catalytic subunit gene family.

Authors:  John C Hutton; Richard M O'Brien
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

3.  Potential positive and negative consequences of ZnT8 inhibition.

Authors:  Kristen E Syring; Karin J Bosma; Slavina B Goleva; Kritika Singh; James K Oeser; Christopher A Lopez; Eric P Skaar; Owen P McGuinness; Lea K Davis; David R Powell; Richard M O'Brien
Journal:  J Endocrinol       Date:  2020-08       Impact factor: 4.286

4.  Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression.

Authors:  Cyrus C Martin; Brian P Flemming; Yingda Wang; James K Oeser; Richard M O'Brien
Journal:  J Mol Endocrinol       Date:  2008-08-27       Impact factor: 5.098

5.  Pancreatic islet beta cell-specific deletion of G6pc2 reduces fasting blood glucose.

Authors:  Karin J Bosma; Mohsin Rahim; Kritika Singh; Slavina B Goleva; Martha L Wall; Jing Xia; Kristen E Syring; James K Oeser; Greg Poffenberger; Owen P McGuinness; Anna L Means; Alvin C Powers; Wen-Hong Li; Lea K Davis; Jamey D Young; Richard M O'Brien
Journal:  J Mol Endocrinol       Date:  2020-05       Impact factor: 5.098

6.  Novel stable isotope analyses demonstrate significant rates of glucose cycling in mouse pancreatic islets.

Authors:  Martha L Wall; Lynley D Pound; Irina Trenary; Richard M O'Brien; Jamey D Young
Journal:  Diabetes       Date:  2014-12-31       Impact factor: 9.461

7.  Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.

Authors:  Maria Veiga-da-Cunha; Nathalie Chevalier; Xavier Stephenne; Jean-Philippe Defour; Nicole Paczia; Alina Ferster; Younes Achouri; Joseph P Dewulf; Carole L Linster; Guido T Bommer; Emile Van Schaftingen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-09       Impact factor: 11.205

Review 8.  Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in Brain-To Maintain Energy-Dependent Functions Including Cognitive Processes.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2020-08-19       Impact factor: 3.996

9.  Novel Approach to Identify Potential Bioactive Plant Metabolites: Pharmacological and Metabolomics Analyses of Ethanol and Hot Water Extracts of Several Canadian Medicinal Plants of the Cree of Eeyou Istchee.

Authors:  Nan Shang; Ammar Saleem; Lina Musallam; Brendan Walshe-Roussel; Alaa Badawi; Alain Cuerrier; John T Arnason; Pierre S Haddad
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression.

Authors:  Kayla A Boortz; Kristen E Syring; Lynley D Pound; Yingda Wang; James K Oeser; Richard M O'Brien
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.